Jiang Zhong Pharmaceutical's Profit Jumps 15% in 2025
MT Newswires Live
Mar 20
Jiang Zhong Pharmaceutical (SHA:600750) posted net profit attributable to shareholders of 906.7 million yuan for 2025, up 15% from 788.2 million yuan a year earlier.
Earnings per share at the drug manufacturer came in at 1.43 yuan, compared with 1.25 yuan a year earlier, according to a Thursday filing by parent China Resources Pharmaceutical (HKG:3320) with the Hong Kong bourse.
Revenue fell 5% to 4.22 billion yuan from 4.44 billion yuan.
The unit proposed a cash dividend of 8.80 yuan per 10 shares, subject to shareholder approval.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.